Retatrutide produced 28.7% body weight loss at 68 weeks in Phase 3 trials
Related Stories GLP-1 weight loss may reduce first-impression penalties in relationships and hiring Weight loss drugs may reduce binge eating disorder symptoms Semaglutide dose may matter more than weight loss for heart health Data collected was weight using calibrated scales, laboratory results for fasting blood glucose [FBG], lipid panel, glycosylated hemoglobin [HbA1c], blood pressure [BP] readings, and liver function tests [LFTs]
Senescent cells were established via DOX-induced senescence
Thats a 0.7% difference - less than a one percentage point absolute risk reduction
For commercial plan sponsors, pharmacy benefit spending grew by 4.0%
Whether after exercise, travel, or extended physical activity, it helps promote a refreshed and comfortable feeling throughout the body.